CDI-31244

DRUG2 trials

Sponsors

Cocrystal Pharma, Inc.

Conditions

Chronic Hepatitis CHepatitis C

Phase 1

A Study of CDI-31244: A Novel NNI in HV and HCV Infected Subjects

CompletedNCT02760758

Cocrystal Pharma, Inc.Hepatitis C

Start: 2016-04-30End: 2017-04-30Updated: 2021-04-20

Phase 2

Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL)

CompletedNCT03501550

Cocrystal Pharma, Inc.Chronic Hepatitis C

Start: 2018-06-26End: 2019-06-07Updated: 2021-04-28